4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
4D Molecular Therapeutics (FDMT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $32.06 M
According to 4D Molecular Therapeutics's latest financial reports the company's total liabilities are $32.06 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
4D Molecular Therapeutics - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $32.06 M | 5.09% |
| 2022-12-31 | $30.5 M | -11.26% |
| 2021-12-31 | $34.38 M | 7.63% |
| 2020-12-31 | $31.94 M | -75.65% |
| 2019-12-31 | $0.13 B | 5.34% |
| 2018-12-31 | $0.12 B | 165.52% |
| 2017-12-31 | $46.91 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -12.92% | 🇺🇸 USA |